Exploration of cardiac biomarkers to decline mortality in COVID-19 Patients


AUTHORS: Sonila Khan, Rabia Yaqoob




Volume:1

Issue: 4

Page: 37-42


Received: 01-Mar-2021

Accepted: 09-Mar-2021


ABSTRACT:COVID 19 disease is caused by SARS CoV-2 had been started from Wuhan, a city of China and affected hundreds of countries has no therapeutic agents known for the treatment. [2] The mortality rate of disease is high with the patients with pre-existing cardiovascular diseases. In some cases, COVID 19 is associated with induction of acute COVID 19 cardiovascular syndromes. The mortality risks of disease can be lessened by early detection of cardiovascular diseases and myocardial injuries by elevated level of cardiac biomarkers more specifically cardiac troponin I (cTnI) and B type natriuretic peptides (BNP)[4] and N terminal pro BNP NT pro BNP) [7]. Virus enters the cardiac cells by specific binding with spike proteins and caused increase destruction of myocardial cells and leading toward the release of specific cardiac troponin in the blood stream.


ISSN

ISSN (Online): 2833-7298
ISSN (Print): 2833-7301

SUBMISSION LAST DATE

30 NOV 2022

CALL FOR PAPER


Volume 2, Issue 11 2022

PROCESSING FEES

Processing fees of papers in IJMRE is:
Indian Author: 2000 Rs
International Author : 50$

MANUSCRIPT TEMPLATE

Requested to All the authors, send original research results according to the given template. Doc & PDF

PUBLICATIONAL LANGUAGE

English


PUBLICATION FREQUENCY

12 Issues per year

PLAGIARISM

There is a zero-tolerance policy towards plagiarigm in our journal. Article are screened for plagiarism before, during, and after publication, and if found they will be rejected at any stage of processing.

ARCHIVES
JOURNAL INDEXING

we will provide youbest guidance in research and innovationover the years

Contact Us